Table 1.

Baseline clinical and laboratory characteristics of the study population and univariate analysis of the variables.

		SYNTAX score
Variable	Overall (n = 110)	Group 1 <22 (n = 69)	Group 2 ⩾22 (n = 41)	p value
Age, years	59 ± 10	55.7 ± 10	57.2 ± 13	0.267
Sex, male %	54	53	56	0.845
Diabetes, %	18	10	31	0.009
Hypertension, %	43	39	49	0.42
Smoking, %	32	33	29	0.679
Dyslipidemia, %	27	23	34	0.269
Family history of CAD	37	36	39	0.839
Systolic blood pressure, mmHg	122 ± 23	122 ± 22	120 ± 23	0.646
Diastolic blood pressure, mmHg	75 ± 17	74 ± 16	76 ± 18	0.534
Heart rate, min	70 (65–97)	70 (62–85)	74 (66–97)	0.253
Visfatin, ng/ml	10.4 ± 5.1	8.6 ± 4.2	13.4 ± 5.2	<0.001
Albumin, g/dl	3.3 (2.8–3.7)	3.1 (2.8–3.7)	3.4 (2.7–3.7)	0.627
C-reactive protein, mg/dl	0.52 (0.29–0.86)	0.46 (0.25–0.77)	0.71 (0.32–1.10)	0.013
NLR	5.5 ± 2.5	5.1 ± 2.4	6.1 ± 2.6	0.033
Hemoglobin, g/dl	12.9 ± 1.4	13.1 ± 1.4	12.7 ± 1.4	0.125
White blood cell count×103/µl	8.6 ± 2.5	8.3 ± 2.4	9.2 ± 2.7	0.094
Platelet count, ×103/µl	263 ± 86	265 ± 85	255 ± 87	0.554
Total cholesterol, mg/dl	222 ± 33	220 ± 36	225 ± 26	0.443
LDL cholesterol, mg/dl	153 ± 30	151 ± 35	157 ± 17	0.323
HDL cholesterol, mg/dl	27 ± 8	27.8 ± 9.2	26.7 ± 5.4	0.459
Triglyceride, mg/dl	205 ± 67	204 ± 62	206 ± 77	0.899
GFR, ml/min	76 ± 17	70 ± 16	76 ± 18	0.103
EF, %	60 ± 5	61 ± 5	59 ± 5	0.090
Previous medications, %
Aspirin	30	29	31	0.831
Statin	19	23	17	0.804
ACE inhibitors/ARB	29	27	31	0.669
β-blocker	13	15	10	0.407

ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; CAD, coronary artery disease; EF, ejection fraction; GFR, glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NLR, neutrophil–lymphocyte ratio.

The normal cutoff value of troponin in our laboratory is <0.04 mg/l.